1.Cloning, expression and immunity of pilA gene and ompC gene from avian pathogenic Escherichia coli.
Shan YU ; Qian ZHANG ; Xiaoxi SHUI ; Zhouliang YU ; Baohua ZHAO
Chinese Journal of Biotechnology 2008;24(9):1561-1567
In order to amplify pilA gene and ompC gene of avian pathogenic Escherichia coli (APEC) strain, two pairs of primers were designed according to the GenBank sequences, and a 549 bp pilA gene and a 1104 bp ompC gene were obtained by PCR separately. Sequence analysis indicated that the homology of the nucleotide sequence of AEPC strain to those other reference strains was 98.18% of the pilA gene and 97.28% of the ompC gene. Two expression plasmids pETpilA and pETompC were constructed by inserting pilA gene and ompC gene into the prokaryotic expression vector pET-28a. The two plasmids were transformated into E. coli BL21 separately and two recombinant strains BL21 (pETpilA) and BL21 (pETompC) were obtained. The type 1 fimbraie and the out membrane protein were highly expressed when the recombinant strain BL21 (pETpilA) and BL21 (pETompC) were induced by IPTG Two specific proteins were detected by SDS-PAGE and immunogenicity of the expressed protein was confirmed by Western blotting and ELISA. The expressed fimbraie and OmpC were transformed into vaccine. The protective immune response was proved after the mice were immunized with the two vaccines. The results showed that the recombinant strain BL21 (pETpilA) and BL21 (pETompC) could be as candidate vaccine to provide protective immune response against AEPC infection.
Animals
;
Cloning, Molecular
;
Escherichia coli
;
genetics
;
immunology
;
metabolism
;
Escherichia coli Proteins
;
genetics
;
immunology
;
metabolism
;
Escherichia coli Vaccines
;
immunology
;
Fimbriae Proteins
;
genetics
;
immunology
;
metabolism
;
Gene Expression Regulation, Bacterial
;
Genes, Bacterial
;
Mice
;
Porins
;
genetics
;
immunology
;
metabolism
;
Recombinant Fusion Proteins
;
genetics
;
immunology
;
metabolism
2.Development and application of a mammlian one hybrid-based high-throughput screening model for Eralpha modulator.
Qian ZHANG ; Xiaoxi SHUI ; Yuling FAN ; Weili HAO ; Zhihui ZHENG ; Xinhua LU ; Baohua ZHAO ; Hua ZHANG ; Jiangong HE
Chinese Journal of Biotechnology 2009;25(7):1088-1094
Estrogen Receptor (ERalpha) is a member of superfamily of ligand-activated transcription factors which play critical roles in many biological processes. To screen novel modulators of ERalpha for drug development and biological function research, we developed a mammalian one-hybrid-based high-throughput screening model for ERalpha modulator. We cloned the ERalpha LBD gene from the total mRNA of fat tissue by RT-PCR and fused it with the GAL4 DNA binding domain of pBIND-GAL4 plasmid to construct a chimara expression plasmid pBIND-GAL4-Eralpha(LBD). The L02 cells was cotransfected with pBIND-GAL4-ERalpha(LBD) and a GAL4-responsive luciferase reporter plasmid pGL3-GAL4, and following treatment with test compounds for 24 h, the activities of luciferase were detected to evaluate the transactivities of ERalpha modulators. After manner optimizations of transfection conditions, Estradiol, an agonist control, induced the expression of luciferase in a dose-dependent with EC50 of 0.17 micromol/L, the maximum folds of induction was about 28.1. Tamoxifen, an antagonist control, efficiently suppressed the estradiol-mediated luciferase induction with EC50 of 0.10 micromol/L. Using this screening model, we discovered four ERalpha agonists from 2000 natural and synthetic compounds.
3T3-L1 Cells
;
Animals
;
Chimera
;
metabolism
;
DNA-Binding Proteins
;
biosynthesis
;
genetics
;
Estrogen Receptor Modulators
;
chemistry
;
isolation & purification
;
Estrogen Receptor alpha
;
agonists
;
Genes, Reporter
;
genetics
;
Genistein
;
chemistry
;
isolation & purification
;
HeLa Cells
;
Humans
;
Luciferases
;
genetics
;
metabolism
;
Mice
;
Models, Chemical
;
Saccharomyces cerevisiae Proteins
;
biosynthesis
;
genetics
;
Transcription Factors
;
biosynthesis
;
genetics
;
Transfection